Page last updated: 2024-10-27

vanoxerine and Adipocere

vanoxerine has been researched along with Adipocere in 1 studies

vanoxerine: structure given in first source
vanoxerine : An N-alkylpiperazine that consists of piperazine bearing 2-bis(4-fluorophenyl)methoxy]ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers. Also a potent sigma ligand (IC50 = 48 nM). Centrally active following systemic administration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Varrone, A1
Steiger, C1
Schou, M1
Takano, A1
Finnema, SJ1
Guilloteau, D1
Gulyás, B1
Halldin, C1

Other Studies

1 other study available for vanoxerine and Adipocere

ArticleYear
In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.
    Synapse (New York, N.Y.), 2009, Volume: 63, Issue:10

    Topics: Animals; Autoradiography; Binding, Competitive; Brain; Citalopram; Dopamine Plasma Membrane Transpor

2009